Potomac, MD, United States of America

Johng S Rhim

USPTO Granted Patents = 8 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 46(Granted Patents)


Location History:

  • Bethesda, MD (US) (1989 - 1995)
  • Potomac, MD (US) (1997 - 2002)

Company Filing History:


Years Active: 1989-2002

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Johng S Rhim

Introduction

Johng S Rhim is a notable inventor based in Potomac, MD (US), recognized for his significant contributions to medical research and biotechnology. He holds a total of 8 patents, showcasing his dedication to advancing scientific knowledge and therapeutic applications.

Latest Patents

Among his latest patents, Rhim has developed immortalized human middle ear epithelial cell lines. These cell lines, transformed by human papilloma viruses, are instrumental in studying gene and protein expression related to otitis media. They also aid in identifying potential chemical and biological agents for treating ear diseases. Additionally, he has created immortalized malignant human prostatic cell lines, which contain DNA from human papillomavirus and activated viral ras oncogenes. These cell lines are valuable for researching treatments for prostatic cancer, benign prostatic hyperplasia, male infertility, and environmental toxic agents.

Career Highlights

Throughout his career, Rhim has collaborated with esteemed institutions, including the United States of America as represented by the Department of Health and Michigan State University. His work has significantly impacted the fields of otology and oncology, contributing to a better understanding of various diseases.

Collaborations

Rhim has worked alongside notable colleagues such as Mukta M Webber and Roger R Reddel, further enhancing the collaborative nature of his research endeavors.

Conclusion

Johng S Rhim's innovative work and patents reflect his commitment to advancing medical research and improving therapeutic strategies. His contributions continue to influence the fields of otitis media and prostate cancer research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…